In recent years, the burden on governments and nongovernmental organizations to create or serve as a catalyst for social change has begun to shift toward ultrawealthy private investors.
Charitably inclined individuals and families increasingly understand that today’s complex global challenges require more than traditional philanthropy, according to Christina Alfonso, chief executive of Madeira Global, an investment advisory firm in New York that specializes in impact investing.
Today, many high-net-worth philanthropists are engaging in impact investing, an approach that aims to generate both financial return and measurable, positive social or environmental change by supporting for-profit enterprises that create sustainable, innovative products and services.
Examples include microfinance, whereby a lender provides small loans to promising startup enterprises, often in developing economies; and a web-based education treatment solution for autism assessment, training and data tracking.
Hot Income Stocks For 2015: Responsys Inc.(MKTG)
Responsys, Inc. provides on-demand software and professional services primarily in North America, the Asia Pacific, and Europe. The company offers Responsys Interact suite, a software-as-a-service platform that provides marketers with a set of integrated applications to create, execute, optimize, and automate marketing campaigns in various channels, including email, mobile, social, and the Web. Its platform also leverages third-party applications and data from real-time sources allowing customers to deliver targeted content to its customers and known prospects as part of their interactive marketing campaigns. In addition, it provides professional services, such as strategic, creative, deliverability, campaign, and education services. The company offers its on-demand software and professional services to retail and consumer, travel, financial services, and technology industries through a direct sales force. Responsys, Inc. was founded in 1998 and is headquartered in San Bru no, California.
Advisors' Opinion:- [By The GeoTeam]
Our recent 2013 articles on SaaS companies Selectica (SLTC), E2open (EOPN), Responsys (MKTG), Vocus (VOCS), and ExactTarget (ET) highlighted such opportunities. The average return since the inception of our coverage currently stands at around 34% (55% at their highs).
Best Healthcare Technology Stocks For 2014: Ascent Solar Technologies Inc.(ASTI)
Ascent Solar Technologies, Inc., a development stage company, focuses on commercializing flexible photovoltaic (PV) modules using its proprietary technology. The company intends to manufacture roll-format PV modules that use copper-indium-gallium-diselenide (CIGS) on a plastic substrate. Its proprietary manufacturing process deposits multiple layers of materials, including a thin-film of CIGS semiconductor material on a plastic substrate and laser patterns the layers to create interconnected PV cells or PV modules through monolithic integration process. The company would serve the building applied photovoltaic (BAPV) and building integrated photovoltaic (BIPV) market, as well as specialty markets, such as defense, portable power, transportation, electronic integrated photovoltaic, and space and near-space. It has a strategic relationship with Norsk Hydro Produksjon AS to access customers in the BIPV/BAPV markets worldwide. Ascent Solar Technologies, Inc. was founded in 200 5 and is based in Thornton, Colorado.
Advisors' Opinion:- [By John Udovich]
Solar stocks have not exactly given buy and hold investors a smooth ride, but small cap�GT Advanced Technologies Inc (NASDAQ: GTAT) could be an interesting materials play on the solar sector���meaning its worth taking a closer look at the stock along with potential peers like Ascent Solar Technologies, Inc (NASDAQ: ASTI) and STR Holdings, Inc (NYSE: STRI) plus solar ETF Guggenheim Solar ETF (NYSEARCA: TAN). I should mention that just last week, we added GT Advanced Technologies to our�SmallCap Network Elite Opportunity (SCN EO) portfolio for both�fundamentals and technical reasons and we are already up almost 9%.
Best Healthcare Technology Stocks For 2014: Medivation Inc.(MDVN)
Medivation, Inc., a biopharmaceutical company, focuses on the development of small molecule drugs for the treatment of castration-resistant prostate cancer, Alzheimer?s disease, and Huntington disease. The company?s product candidates under clinical development include MDV3100, which is in Phase 3 development for the treatment of castration-resistant prostate cancer; and dimebon, which is in Phase 3 clinical trial for the treatment of Alzheimer?s disease and Huntington disease. It has collaboration agreements with Pfizer Inc. to develop and commercialize dimebon; and Astellas Pharma Inc. to develop and commercialize MDV3100. The company was founded in 2003 and is based in San Francisco, California.
Advisors' Opinion:- [By Brian Orelli]
The largest impact to sales came from competition from new prostate cancer drugs Johnson & Johnson's (NYSE: JNJ ) Zytiga and Astellas Pharma and Medivation's (NASDAQ: MDVN ) Xtandi. In December, Zytiga was approved for use in patients who haven't received chemotherapy, the same patients that Provenge is approved to treat. Xtandi is still only approved as a second-line treatment after chemotherapy, but is listed as an earlier treatment in the National Comprehensive Cancer Network Compendium, the oncologist's bible for off-label treatment that insurers often use to make coverage decisions.
- [By Ben Levisohn]
Werber and Eckhard’s favorites include Gilead (GILD) and Celgene (CELG), and they find the “risk/reward…compelling” in Medivation (MDVN) and Tesaro (TSRO).
- [By Ben Levisohn]
While we lean positive on the large cap names across the board, including Neutral-rated names [Biogen (BIIB)] and [Celgene (CELG)], we single out [Gilead Sciences (GILD)] as our favourite into YE13e and into 2014. Among mid caps, we favor…[Medivation (MDVN).]
- [By Sean Williams]
A slew of competitors
We've had two treatments recently approved by the FDA a full three months ahead of their PDUFA date: Medivation (NASDAQ: MDVN ) and Astella Pharma's Xtandi, and Bayer and Algeta's Xofigo. Xtandi improved median overall survival to 18.4 months, compared with just 13.6 months for the placebo in trials while Xofigo's median overall survival tallied 14 months, compared with 11.2 months for the control arm.
Best Healthcare Technology Stocks For 2014: PokerTek Inc.(PTEK)
PokerTek, Inc., together with its subsidiaries, engages in the development, manufacture, and marketing of electronic table games and related products for casinos, cruise lines, racinos, card clubs, and lotteries worldwide. Its products include PokerPro system, an automated 10-seated poker table with electronic components that allows players to play live poker against one another in a brick and mortar environment using electronic cards and chips by supporting poker, cash games, tournaments, and various languages; and Blackjack Pro, which offers the traditional game of Blackjack on the new ProCore automated table game platform, as well as allows operators to configure the game rules and payouts to meet their needs. The company distributes its gaming products using internal sales force and select distributors. PokerTek, Inc. was founded in 2003 and is headquartered in Matthews, North Carolina.
Advisors' Opinion:- [By James Brumley]
With the stock down more than 13% since early March, it would be easy to assume Multimedia Games Holding Company (MGAM) was headed for a nasty earnings report at the end of April. The market was wrong, however. MGAM posted a 25% increase in revenue for the quarter, and a 28% improvement in earnings … and that was before the acquisition of PokerTek (PTEK). Bringing PokertTek into the fold will almost assure a fourth straight year of revenue and income growth.
Best Healthcare Technology Stocks For 2014: Dole Food Company Inc(DOLE)
Dole Food Company, Inc. engages in sourcing, growing, processing, marketing, and distributing fresh fruits and vegetables, and food products to wholesale, retail, and institutional customers worldwide. It operates in three segments: Fresh Fruit, Fresh Vegetables, and Packaged Foods. The Fresh Fruit segment involves in growing and selling bananas under the DOLE brand name primarily in North America, Europe, and Asia; ripening and distributing DOLE and non-DOLE branded fresh produce in Europe; growing, sourcing, and selling fresh pineapples under the DOLE TROPICAL GOLD label; and exporting Chilean fruits, including grapes, apples, pears, stone fruits, and kiwifruits primarily to North America, Latin America, and Europe. The Fresh Vegetables segment engages in sourcing, harvesting, cooling, distributing, and marketing various fresh and fresh-cut vegetables, including iceberg lettuce, red and green leaf lettuce, romaine lettuce, butter lettuce, celery, cauliflower, broccoli, c arrots, Brussels sprouts, green onions, asparagus, snow peas, artichokes, and radishes, as well as fresh strawberries and raspberries. This segment also processes and markets value-added vegetable products, such as packaged salads and packaged fresh-cut vegetables. The Packaged Foods segment produces and markets canned pineapples, canned pineapple juice, fruit juice concentrate, fruit parfaits, snack foods, and frozen fruits, as well as fruits in plastic cups, jars, and pouches. Its principal customers include mass merchandisers and supermarkets. Dole Food Company, Inc. was founded in 1851 and is based in Westlake Village, California.
Advisors' Opinion:- [By Eric Volkman]
It didn't take long for Dole Foods (NYSE: DOLE ) to reverse its policy on stock repurchases. Less than three weeks after initiating a buyback program, the company has suspended it. Instead, it will plow capital into upgrading its fleet of ships, a project it anticipates will cost roughly $165 million.
Best Healthcare Technology Stocks For 2014: Rubicon Minerals Corp(RBY)
Rubicon Minerals Corporation, a mineral exploration company, engages in the acquisition, exploration, and development of mineral properties in Canada and the United States. It primarily explores for gold and base metal deposits. The company?s key asset is the Phoenix Gold Project located in the Red Lake gold camp, in the Province of Ontario. As of March 31, 2010, it controlled approximately 65,000 acres of prime exploration ground in the prolific Red Lake gold district of Ontario, Canada, as well as approximately 380,000 acres surrounding the Pogo Mine in Alaska and approximately 225,000 acres in northeast Nevada. The company was founded in 1996 and is headquartered in Vancouver, Canada.
Advisors' Opinion:- [By Sean Williams]
Another reason this fund looks attractive (at least to me) is that Rubicon Minerals (NYSEMKT: RBY ) is one of its largest holdings at 6.02% of its assets as of May 10, 2013. Rubicon is in the late stages of the development process for the F2 Gold System, which has yielded drilling assessments as high as 767 grams/ton. F2 appears to be just as bountiful in gold well below the surface as it is near the surface, which could mean a very long and profitable mine life for Rubicon.
No comments:
Post a Comment